These findings indicated the inhibition effect of Aβ12-28P of Aβ deposition in vivo and demonstrated that compounds blocking the interaction between Aβ and its pathological chaperone ApoE may be beneficial for treatment of Aβ deposition in AD [37]. This evidence concerns the gene APOE and Alzheimer disease.